Buscar

Mostrando ítems 1-10 de 15

Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry

2019- Mena-Vazquez, N.; Fernandez-Nebro, A.; Pego Reigosa, José María; Galindo, M.; Melissa-Anzola, A.; [et al.]

Comment on: Comorbidities (excluding lymphoma) in Sjögren's syndrome. Reply

2021- Pego Reigosa, José María; Rúa-Figueroa Fernández de Larrinoa, Í

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes

2020- Rúa-Figueroa, Iñigo; López-Longo, Francisco J; Del Campo, Víctor; Galindo-Izquierdo, María; Uriarte, Esther; [et al.]

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies

2020- Sanchez-Piedra, C.; Diaz-Torne, C.; Manero, J.; Pego Reigosa, José María; Rua-Figueroa, I.; [et al.]

Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort

2019- Tejera Segura, B.; Rua-Figueroa, I.; Pego Reigosa, José María; del Campo Pérez, Victor Miguel; Wincup, C.; [et al.]

Semaphorin4A-Plexin D1 Axis Induces Th2 and Th17 While Represses Th1 Skewing in an Autocrine Manner

2020- Carvalheiro, T.; Rafael-Vidal, C.; Malvar-Fernandez, B.; Lopes, A. P.; Pego Reigosa, José María; [et al.]

Angiopoietin-2 Promotes Inflammatory Activation in Monocytes of Systemic Sclerosis Patients

2020- Carvalheiro, T.; Lopes, A. P.; van der Kroef, M.; Malvar-Fernandez, B.; Rafael-Vidal, C.; [et al.]

Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases

2020- Rafael-Vidal, C.; Pérez Gómez, Nair; Altabás, I.; Garcia, S.; Pego Reigosa, José María

Prevalence of systemic lupus erythematosus in Spain: higher than previously reported in other countries?

2020- Cortés-Verdú, Raúl; Pego Reigosa, José María; Seoane-Mato, Daniel; Morcillo Valle, Mercedes; Palma Sánchez, Deseada; [et al.]

Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis

2021- Vidal Pérez, Rafael Carlos; Altabas Gonzalez, Irene; Pérez Gómez, Nair; Mouriño Rodriguez, Coral; Pego Reigosa, José María; [et al.]

1
2